Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented final first-in-human data for ...
As artificial intelligence (AI) heavyweights concede the technology may one day develop consciousness, academics warn that humans are already treating bots as sentient beings – a trend that is not ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果